1
/
의
1
ELK Biotechnology
SKU(재고 관리 코드):ELK1008
Human EG-VEGF(Endocrine Gland Derived Vascular Endothelial Growth Factor) ELISA Kit
Human EG-VEGF(Endocrine Gland Derived Vascular Endothelial Growth Factor) ELISA Kit
Human EG-VEGF(Endocrine Gland Derived Vascular Endothelial Growth Factor) ELISA Kit
Overview
| Product name: | Human EG-VEGF(Endocrine Gland Derived Vascular Endothelial Growth Factor) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | PK1; EGVEGF; PRK1, PROK1; Prokineticin 1; Black Mamba Toxin-Related Protein; Mambakine |
| Assay Type: | Sandwich |
| Sensitivity: | 6.5 pg/mL |
| Standard: | 1000 pg/mL |
| Detection Range: | 15.63-1000 pg/mL |
| Sample Type: | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Assay Length: | 3.5h |
| Research Area: | Cytokine;Tumor immunity; |
| Test principle: | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human EG-VEGF. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human EG-VEGF. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human EG-VEGF, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human EG-VEGF in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 1000.00 | 2.266 | 2.083 |
| 500.00 | 1.803 | 1.620 |
| 250.00 | 1.386 | 1.203 |
| 125.00 | 0.971 | 0.788 |
| 62.50 | 0.630 | 0.447 |
| 31.25 | 0.414 | 0.231 |
| 15.63 | 0.252 | 0.069 |
| 0.00 | 0.183 | 0.000 |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant EG-VEGF and the recovery rates were calculated by comparing the measured value to the expected amount of EG-VEGF in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 82-95% | 88% |
| EDTA plasma(n=5) | 85-97% | 91% |
| Heparin plasma(n=5) | 79-93% | 86% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of EG-VEGF and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 95-104% | 97-106% | 85-98% | 81-92% |
| EDTA plasma(n=5) | 83-92% | 96-102% | 81-93% | 79-91% |
| Heparin plasma(n=5) | 89-101% | 85-96% | 95-104% | 82-90% |
Share
